The field of ancient DNA, which combines archaeology and anthropology with cutting-edge genetics, is requiring scientists to have frank conversations about when research is justified and who it benefits.
Brianna Chrisman and Jordan Eizenga | Sep 1, 2022 | 10+ min read
Thirty years out from the start of the Human Genome Project, researchers have finally finished sequencing the full 3 billion bases of a person’s genetic code. But even a complete reference genome has its shortcomings.
Almost 60 percent of people in a new study on attitudes in the US felt comfortable using animals to grow human organs from induced pluripotent stem cells.
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
For years, a committee at CNRS has bucked the recommendations of its researchers to hire two social scientists, and colleagues conclude that prejudice is at play.
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.